Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Lymphocytic, Chronic, B-Cell

Explore clinical trials studying Leukemia, Lymphocytic, Chronic, B-Cell. Study availability and eligibility vary by location and protocol.

1,435 public trials 165 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Lymphocytic, Chronic, B-Cell trial results

Completed

A Study to Evaluate the Efficacy of Venetoclax Monotherapy in Relapsed/Refractory Participants With Chronic Lymphocytic Leukemia (CLL)

NCT02756611

Conditions
Chromosome 17 deletion, Chronic Disease, Chronic Lymphocytic Leukemia, +16 more
Locations
  • Norton Cancer Institute /ID# 149788 Louisville, Kentucky, United States
  • St. Agnes Cancer Center /ID# 149782 Baltimore, Maryland, United States
  • Hackensack Univ Med Ctr /ID# 151574 Hackensack, New Jersey, United States
  • Utah Cancer Specialists /ID# 151604 Salt Lake City, Utah, United States
View all 67 locations
View Trial Details
Completed

Study to Describe the Management and the Use of Healthcare Resources in Patients With Chronic Lymphocytic Leukemia (CLL) Initiating Venetoclax in Routine Clinical Practice

NCT03310190

Conditions
Chromosome 17 deletion, Chronic Disease, Chronic Lymphocytic Leukemia, +15 more
Locations
  • University of Calgary /ID# 166416 Calgary, Alberta, Canada
  • Cross Cancer Institute /ID# 166417 Edmonton, Alberta, Canada
  • Jack Ady Cancer Centre /ID# 217491 Lethbridge, Alberta, Canada
  • CancerCare Manitoba /ID# 170751 Winnipeg, Manitoba, Canada
View all 13 locations
View Trial Details
Completed

A Study to Evaluate the Safety, Tolerability, and Efficacy of Relatlimab in Relapsed or Refractory B-Cell Malignancies

NCT02061761

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +19 more
Locations
  • Local Institution - 0007 Baltimore, Maryland, United States
  • Local Institution - 0004 Boston, Massachusetts, United States
  • Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
  • Local Institution - 0010 St Louis, Missouri, United States
View Trial Details
Completed

A Study Evaluating the Impact of Venetoclax on the Quality of Life for Subjects With Relapsed (Your Cancer Has Come Back) or Refractory (no Response to Previous Cancer Treatments) Chronic Lymphocytic Leukemia (CLL) While Receiving Venetoclax Monotherapy (a Single Agent).

NCT02980731

Conditions
Chromosome 17 deletion, Chronic Disease, Chronic Lymphocytic Leukemia (CLL), +15 more
Locations
  • Hospital Italiano La Plata /ID# 150812 La Plata, Buenos Aires, Argentina
  • Fundaleu /Id# 150811 Ciudad Autonoma de Buenos Aire, Ciuadad Autonoma de Buenos Aires, Argentina
  • Cemic /Id# 150810 Ciudad Autonoma de Buenos Aire, Ciuadad Autonoma de Buenos Aires, Argentina
  • Sanatorio Allende /ID# 150813 Córdoba, Argentina
View all 33 locations
View Trial Details

Related conditions